{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137045201906432.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/j.1540-8183.2010.00581.x"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1540-8183.2010.00581.x"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1540-8183.2010.00581.x"}}],"dc:title":[{"@value":"Comparison of Risks and Clinical Predictors of Contrast‐Induced Nephropathy in Patients Undergoing Emergency versus Nonemergency Percutaneous Coronary Interventions"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p> <jats:bold>\n            <jats:italic>Background:</jats:italic>\n          </jats:bold> <jats:italic>Contrast nephropathy (CIN) increases adverse clinical outcomes. We examine risks and clinical predictors of CIN in patients undergoing percutaneous coronary intervention (PCI) and effectiveness of prophylactic therapy.</jats:italic></jats:p><jats:p> <jats:bold>\n            <jats:italic>Methods:</jats:italic>\n          </jats:bold> <jats:italic>A cohort of 8,798 patients who underwent PCI from May 2000 to April 2008 was enrolled. We divided patients into 3 groups. A: STEMI patient undergoing primary PCI; B: UA/NSTEMI patients undergoing early PCI; C: Patients without MI undergoing elective PCI. Pre‐PCI saline hydration was given to group B and C if baseline glomerular filtration rate (GFR) <60 ml/min/1.73 m<jats:sup>2</jats:sup>.</jats:italic></jats:p><jats:p> <jats:bold>\n            <jats:italic>Results:</jats:italic>\n          </jats:bold> <jats:italic>Mean age was 57.4 years; 35.9% was diabetics. Incidence of CIN were 12.0%, 9.2%, and 4.5%, in group A, B and C (P = <0.0005). CIN correlated with higher mortality (15.5% vs. 1.3%, P < 0.0005) at 1 month. The important predictors of CIN were age >70, female gender, anemia, low systolic BP < 100 mmHg, high creatinine kinase level, abnormal LVEF, baseline renal impairment, MI and insulin dependent diabetes. Incidence of CIN in patients with GFR >60 were 8.2%, 9.2%, and 4.3% in group A, B, and C respectively (p < 0.0005). Incidence of CIN in patients with GFR = 30–60 were 19.1%, 4.5%, and 2.4% (p < 0.0005) and in patients with GFR < 30 were 34.4%, 40.0%, and 25.9% (p = 0.510).</jats:italic></jats:p><jats:p> <jats:bold>\n            <jats:italic>Conclusions:</jats:italic>\n          </jats:bold> <jats:italic>Pre‐hydration prophylaxis was effective in preventing CIN in mild renal impaired patients (GFR 30–60) but are less so in more severely renal impaired patients (GFR < 30). STEMI patients undergoing primary PCI regardless of baseline GFR were at high risk. Accelerated prophylactic regime can be considered in this cohort.</jats:italic> (J Interven Cardiol 2010;23:451–459)</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137045201906436","@type":"Researcher","foaf:name":[{"@value":"ERIC CHONG"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045201906432","@type":"Researcher","foaf:name":[{"@value":"KIAN K. POH"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045201906434","@type":"Researcher","foaf:name":[{"@value":"SHEN LIANG"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137045201906435","@type":"Researcher","foaf:name":[{"@value":"CHAO Y. SOON"}]},{"@id":"https://cir.nii.ac.jp/crid/1380861404577891840","@type":"Researcher","foaf:name":[{"@value":"HUAY‐CHEEM TAN"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"08964327"},{"@type":"EISSN","@value":"15408183"}],"prism:publicationName":[{"@value":"Journal of Interventional Cardiology"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2010-08-27","prism:volume":"23","prism:number":"5","prism:startingPage":"451","prism:endingPage":"459"},"reviewed":"false","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1540-8183.2010.00581.x"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1540-8183.2010.00581.x"}],"createdAt":"2010-08-30","modifiedAt":"2023-11-02","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565165931735936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of Periprocedural Bleeding on Incidence of Contrast-Induced Acute Kidney Injury in Patients Treated With Percutaneous Coronary Intervention"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205107053184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prognostic Value of Chronic Kidney Disease Measures in Patients With Cardiac Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205109243008","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Predictors of Contrast-Induced Acute Kidney Injury in Patients Undergoing Emergency Versus Elective Percutaneous Coronary Intervention"},{"@value":"Clinical Predictors of Contrast-Induced Acute Kidney Injury in Patients Undergoing Emergency Versus Elective Percutaneous Coronary Intervention : Results From the Ibaraki Cardiovascular Assessment Study Registry"},{"@value":"Minimizing Contrast Dose According to Estimated Glomerular Filtration Rate"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282752372831360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018"},{"@value":"JCS GUIDELINES : Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018"}]},{"@id":"https://cir.nii.ac.jp/crid/1390860609154095104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Dynamic Changes in the Renal Function of Acute Myocardial Infarction Patients with Reduced eGFR After Emergency Percutaneous Coronary Intervention"}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942143993216","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Guidelines on the use of iodinated contrast media in patients with kidney disease 2012 : digest version"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/j.1540-8183.2010.00581.x"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-19-0783_references_DOI_U7tZraXfhvyPgRtQ9OMZ8Rf0A8m"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-13-0574_references_DOI_U7tZraXfhvyPgRtQ9OMZ8Rf0A8m"},{"@type":"CROSSREF","@value":"10.1536/ihj.23-102_references_DOI_U7tZraXfhvyPgRtQ9OMZ8Rf0A8m"},{"@type":"CROSSREF","@value":"10.1016/j.jacc.2013.03.086_references_DOI_U7tZraXfhvyPgRtQ9OMZ8Rf0A8m"},{"@type":"CROSSREF","@value":"10.1007/s11604-019-00850-2_references_DOI_U7tZraXfhvyPgRtQ9OMZ8Rf0A8m"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-17-0550_references_DOI_U7tZraXfhvyPgRtQ9OMZ8Rf0A8m"},{"@type":"CROSSREF","@value":"10.1007/s11604-013-0226-4_references_DOI_U7tZraXfhvyPgRtQ9OMZ8Rf0A8m"}]}